1 |
Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone 2011;49(1):56-65.
DOI
|
2 |
최성욱, 김상림, 이광복, et al. 골다공증 환자에서 경구 비스포스포네이트 치료 중 발생한 악골 괴사. 대한정형외과학회지 2010;45(2):151-154.
DOI
|
3 |
이덕원, 이현우, 권용대. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) 에 대한 biochemical bone markers 와 악골괴사와 연관된 nonbisphosphonate drugs. 대한치과의사협회지 2014;52(4):203-217.
|
4 |
김경민, 이유미. 종설 : 비스포스포네이트의 치료 기간. 대한내과학회지 2014;87(2):151-155.
|
5 |
Won Y, Lim JR, Kim YH, et al. Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab 2014;21(2):155-159.
DOI
|
6 |
안기찬, 박대현, 공규민, et al. 원저 : 지속적인 비스포스포네이트 제제 사용으로 발생한 대퇴부 부전 골절의 치료 및 경과. 대한골절학회지 2014;27(1):10-16.
|
7 |
Ruggiero SL, Dodson TB, Fantasia J, et al. 2014 AAOMS Position Paper on Medication-Related Osteonecrosis of the Jaw. American Association of Oral and Maxillofacial Surgeons; 2014. Available from:http://www.aaoms.org/index.php.
|
8 |
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of Oral and Maxillofacial Surgery 2003;61(9):1115-1117.
DOI
|
9 |
Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate?Related Osteonecrosis of the Jaw?2009 Update. Australian endodontic journal 2009;35(3):119-130.
DOI
|
10 |
Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw?2014 Update. Journal of Oral and Maxillofacial Surgery 2014.
|
11 |
박용덕, 김영란, 김덕윤, et al. 한국인 치과의사의 비스포스포네이트 관련 악골괴사에 대한 인식 연구. 대한구강악안면외과학회지 2009;35(3):153-157.
|
12 |
강경연. 비스포스포네이트 관련 악골괴사(BRONJ) 에 관한 서울시 치과위생사의 인식도 조사. 서울: 이화여자대학교 임상치의학대학원; 2014.
|
13 |
Al-Mohaya MA, Al-Khashan HI, Mishriky AM, Al- Otaibi LM. Physicians' awareness of bisphos phonates-related osteonecrosis of the jaw. Saudi Med J 2011;32(8):830-835.
|
14 |
Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39(2):175-191.
DOI
|
15 |
오지수, 김수관, 유재식, et al. 종설 : 비스포스포 네이트 관련 악골 골괴사: 문헌고찰. 口腔生物學 硏究2014;38(1):1-8.
|
16 |
Katz J, Ordoveza PA. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) associated with a once-yearly IV infusion of zoledronic acid (Reclast) 5 mg: two cases and review of the literature. Quintessence Int 2014;45(8):685-690.
|
17 |
Lam DK, Sandor GK, Holmes HI, et al. A review of bisphosphonate-associated osteonecrosis of the jaws and its management. J Can Dent Assoc 2007;73(5):417-422.
|
18 |
Khosla S, Burr D, Cauley J, et al. Bisphosphonateassociated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22(10):1479-1491.
DOI
|
19 |
Do Jung S, Son HR, Chung YJ, Mo JH. A Case of Sinusitis due to Bisphosphonate Related Osteonecrosis of Jaw. Korean J Otorhinolaryngol-Head Neck Surg 2012;55:590-594.
DOI
|